Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousHematopoietic Stem Cell MobilizationTransplantation ConditioningStem Cell TransplantationHematologic NeoplasmsGraft vs Host DiseaseLeukapheresisGranulocyte Colony-Stimulating FactorMelphalanAntigens, CD34Blood Component RemovalCombined Modality TherapyBone Marrow TransplantationGraft SurvivalCyclophosphamideHematopoietic Stem CellsBusulfanMultiple MyelomaMyeloablative AgonistsTreatment OutcomeStem CellsAntineoplastic Combined Chemotherapy ProtocolsCord Blood Stem Cell TransplantationTransplantation ChimeraRecurrenceTissue DonorsRemission InductionAntineoplastic Agents, AlkylatingLymphoma, Non-HodgkinEtoposideHistocompatibilityPOEMS SyndromeThiotepaWhole-Body IrradiationHistocompatibility TestingDisease-Free SurvivalInfectionTransplantation, IsogeneicImmunosuppressive AgentsVidarabineRetrospective StudiesHematopoiesisAmyloidosisLeukemiaSalvage TherapyIfosfamideSurvival RateVincristineSurvival AnalysisBlood CellsCarmustineGraft vs Leukemia EffectCytarabineTime FactorsHodgkin DiseaseLeukemia, Myeloid, AcutePlatelet CountMyelodysplastic SyndromesCytomegalovirus InfectionsAnemia, AplasticBlood Cell CountLymphomaCytophagocytosisLiver TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveNeoplasmsLymphocyte DepletionFatal OutcomeLivedo ReticularisFeasibility StudiesHistiocytosis, Non-Langerhans-CellFollow-Up StudiesDoxorubicinOpportunistic InfectionsHematologic DiseasesCyclosporinePrecursor Cell Lymphoblastic Leukemia-LymphomaHLA AntigensBlood DonorsBone MarrowImmunophenotypingRecombinant ProteinsImmunosuppressionMesenchymal Stem Cell TransplantationProspective StudiesLymphoma, T-CellAntineoplastic AgentsBone Marrow PurgingPilot ProjectsPrednisoneCarboplatinFlow CytometryBone Marrow DiseasesAntigens, CDPrognosisT-LymphocytesBlood Group Incompatibility